Sign in to view content

Changes in Hyperautofluorescence Area and RPE/Outer Retinal Layer Thickness in the Phase 2a SIGLEC Study Assessing AVD-104 for the Treatment of GA

Carl D. Regillo, MD

Video
Published 2025

Related

GATHER2 Phase 3 Efficacy Results and GATHER2 Phase 3 Safety Results
Jeffrey S. Heier, MD
Arshad M. Khanani, MD, MA, FASRS
Updates from the Field
2022
Primary Analysis Results of the Phase 3 Archway Trial of the Port Delivery System With Ranibizumab (PDS) for Patients With Neovascular AMD
Peter A. Campochiaro, MD
Annual Meeting Talks
2020
Ten-Year Follow-Up of Patients With Exudative Age-Related Macular Degeneration Treated With Intravitreal Anti-VEGF Injections
Sophie Jane Bakri, MD
Annual Meeting Talks
2020

Category: AMD-Non-Neovascular

See more